Evidence map›Paper›PMID 40821030›Full record

ArticleAmerican journal of translational research2025

Application analysis of an internet platform tracking management mode combined with progressive resistance training in the rehabilitation of patients with breast cancer-related lymphedema.

Xiaofei Wu, Dongyang Zeng, Chuangyang Lin, Xiangwen Wang, Hongmei Xin

Abstract read
In one paragraph

Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaofei WuDepartment of Nursing, Hainan Health Vocational College Haikou 570311, Hainan, China.
Dongyang ZengInternational Nursing School, Hainan Medical University Haikou 571199, Hainan, China.
Chuangyang LinDepartment of Breast Surgery, Hainan General Hospital Haikou 570311, Hainan, China.
Xiangwen WangDepartment of Radiation Oncology, Hainan Cancer Hospital Haikou 570311, Hainan, China.
Hongmei XinDepartment of Breast Surgery, Hainan General Hospital Haikou 570311, Hainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo observe the influence of internet platform tracking management mode combined with progressive resistance training (PRT) on the rehabilitation of patients with breast cancer-related lymphedema (BCRL).

methodsA total of 100 patients with BCRL admitted to Hainan general hospital from January 2023 to March 2024 were selected. After the shedding cases were excluded, they were divided into group A (n=47) where PRT + out-of-hospital follow-up were given, and group B (n=48) where PRT + Internet platform tracking management mode was given. The two groups were compared in peripheral diameter difference, volume difference, lymphatic flow, edema degree, grip strength, shoulder joint activity of the upper limbs, daily living function and quality of life.

resultsThe peripheral diameter difference, volume difference, proportion of severe edema and Disabilities of the Arm, Shoulder and Hand (DASH) scores of upper limbs in the two groups were decreased after 4 weeks and 12 weeks of intervention, while those in the group B were even lower (

conclusionThe application of the internet platform tracking management mode combined with PRT in patients with BCRL can reduce the degree of edema, improve the grip strength, enhance the shoulder joint activity, and improve the function of daily living.

Indexed as

activitybreast cancer-related lymphedemaInternet platform tracking management modeprogressive resistance training

Identifiers

PMID40821030
PMCPMC12351570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.